Beats Medical Group

Leading Digital Therapeutics company, on a mission to empower every person with a neurological or CNS condition to enjoy a better quality of life.

[Beats Medical Group @BeatsMedical]

Beats Medical are extremely proud to become the first Parkinson's-specific app to be featured in the @ParkinsonsUK App & Device library, which tests and approves safe and effective apps to help people with #Parkinsons https://t.co/4fZvACYqZf

[Beats Medical Group @BeatsMedical]

Our COO Andrew Phelan has recently shared his insights and thoughts for 2024, predicting the dominating trends we expect to see in the #digitalhealth industry. We believe 2024 will be a turning point for digital healthcare!

Read more: https://t.co/8el5BNpOlR

[Andrew Phelan @AndrewPhelan8]

In 2024, the #pharma industry and #digital health will undergo significant transformations. Four key trends for the upcoming year will reshape digital health and enhance pharma's ability to deliver new therapeutic breakthroughs. Read more: https://t.co/A0k88yyJpy

[Beats Medical Group @BeatsMedical]

The integration of #digital technologies is reshaping #healthcare as we know it, ushering in an era of personalised medicine and patient-centred care.

Apply to join the discussion on #digitalbiomarkers, featuring our CEO Ciara Clancy here: https://t.co/mn8hFFXyP1

[Beats Medical Group @BeatsMedical]

From one centralised platform, we deploy and integrate our technology into and across our #pharma partners pipelines.

If you are interested in deploying #digital tools to support your clinical trials or to provide interventions, read more at: https://t.co/ibbtgzbrpS

#DTx #CNS

[Beats Medical Group @BeatsMedical]

We’ve recently published an article diving into the widely recognised Timed Up and Go #assessment that we've digitised to offer more precise measurements of movement, balance and gait, reducing the dependence on subjective observations.

Read: https://t.co/p28PWdLRIW

#CNS #DTx

[Beats Medical Group @BeatsMedical]

The team at Beats Medical would like to wish all of our followers, friends, partners and colleagues a very Happy Christmas and New Year. We look forward to reigniting conversations in 2024, taking another step towards the future of healthcare.

#DTx #digitaltherapeutics #CNS

[Beats Medical Group @BeatsMedical]

We're taking the opportunity to reflect on the growth of our agile team, how we have enhanced our product offerings, proven our approach with global #pharma partners and shared our unique perspectives. We’re looking forward to accelerating #healthcare through 2024 and beyond.

[Beats Medical Group @BeatsMedical]

Only through our precision assessments, combined with the long-term behavioural changes that our #digitaltherapeutics create can we truly unlock the value of #digitalbiomarkers with our #pharma partners.

Read more or schedule a demo today: https://t.co/ibbtgzbrpS

[Beats Medical Group @BeatsMedical]

We work with #pharma partners who are driven to transform the lives of patients through innovation. We partner for scale with a promise of shared success.

Contact our team, or email [email protected] to explore how we can accelerate your #CNS or #rare disease pipeline.

[Beats Medical Group @BeatsMedical]

Our Colbolt platform has been deployed through our flagship products out of a necessity to provide solutions for the people who need them most.

Contact our team to explore how we can work with #pharma partners to deploy digital solutions across #CNS and #rare conditions.

#DTx

[Beats Medical Group @BeatsMedical]

Did you know that our platform can be deployed as an assessment only solution? The enhanced objectivity, reliability & sensitivity of the data we capture supports better #clinical #trials, fuels #digitaltherapeutic solutions and builds foundations for #digitalbiomarker discovery.

[Beats Medical Group @BeatsMedical]

Check out a recent interview with our COO Andrew Phelan, who explores our Colbolt platform, built over 8 years and powered by our AI and ML algorithms.

We digitise clinical assessments and deliver individually prescribed therapies to end users.

#CNS #raredisease #DTx

[Beats Medical Group @BeatsMedical]

By offering assessment-only solutions for #decentralizedclinicaltrials, we have unlocked the potential to gather more granular data, surpassing in-clinic methods. For #Pharma partners, this can add revenue streams, faster time-to-market, and more product diversification.

[Beats Medical Group @BeatsMedical]

We address an unmet need for patients with CNS or rare conditions to revolutionise how we understand, treat and manage their conditions. Contact our team to explore potential partnership opportunities.

#DTx #digitaltherapeutics #digitalhealth #CNS #raredisease #innovation

[Beats Medical Group @BeatsMedical]

October 10th marks World Mental Health day.

This is an opportunity to unite behind the theme ‘Mental health is a universal human right' to improve knowledge, raise awareness and drive actions that promote and protect everyone’s mental health.

#WorldMentalHealthDay

[Beats Medical Group @BeatsMedical]

This week is #Dyspraxia Awareness Week, dedicated to raising awareness for the condition.

We have been lucky to work with many inspiring children with Dyspraxia who have used our technology.

Our goal is to support even more people with #CNS or rare conditions around the world.

[Beats Medical Group @BeatsMedical]

As we close the third quarter of 2023, we wanted to reflect on what our team have been up to over the last few months!

We are proud to have a committed, cross-functional team. Our combined experience puts Beats Medical at the forefront of the #DigitalTherapeutics industry.

[Beats Medical Group @BeatsMedical]

This month we are celebrating Beats Medical’s 11th birthday!

We are proud of our incredible team, the innovation we have brought and continue to bring to life, and our dedication to unlocking the therapies of the future.

#CNS #DTx #digitaltherapeutics #digitalbiomarkers

[Beats Medical Group @BeatsMedical]

Through our patented sensor adaptations and algorithms, Beats Medical outperform state-of-the-art technology in the measurement of altered movement and speech patterns seen in #CNS Conditions and Rare Disease.

Read more: https://t.co/yn6RpVPqvT

#DTx #digitaltherapeutics

[Beats Medical Group @BeatsMedical]

#Digital assessments and #therapeutics can accelerate the #healthcare industry, increasing access to evidence-based #therapies that are safe and effective.

Here are some of the problem areas that we can address, through our intelligent Colbolt platform and patented approach.